Kuria Therapeutics, Inc.
Little Rock, AR Kuria Therapeutics, Inc.
- UEI
- F7M7TD9GDA55
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9 Trafalgar Cove, Little Rock, AR 72210, USA
- Website
- kuriatx.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Testing of SCO-116, an NRF2 activator for fuchs' dystrophy, in cultured human corneas - abstract corneal endothelial… | National Eye Institute | $306,805 | |
| IND-enabling studies of KTX-1161, a novel NRF2 activator for corneal endothelial disease - abstract this proposal by… | National Eye Institute | $799,730 |
Quick answers
What is Kuria Therapeutics, Inc.'s UEI?
Kuria Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is F7M7TD9GDA55.
Where is Kuria Therapeutics, Inc. located?
Kuria Therapeutics, Inc.'s physical address in SAM.gov is 9 Trafalgar Cove, Little Rock, AR 72210, USA.
Is Kuria Therapeutics, Inc. registered in SAM.gov?
Yes. Kuria Therapeutics, Inc.'s SAM.gov registration is active through November 3, 2026.
What is Kuria Therapeutics, Inc.'s most recent federal award?
Kuria Therapeutics, Inc.'s most recent federal grant award is Testing of SCO-116, an NRF2 activator for fuchs' dystrophy, in cultured human corneas - abstract corneal endothelial… (R43EY038532), from National Eye Institute, on September 1, 2026.
On GovTribe
See Kuria Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors